Risk factors for the development of diabetes mellitus in chronic HCV genotype 4 infection.
Mohamed
Mostafa K
MK
D000367:Age Factors; D000998:Antiviral Agents / Q000627:therapeutic use; D001786:Blood Glucose / Q000187:drug effects; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000208:ethnology / Q000235:genetics / Q000821:virology*; D004534:Egypt / Q000208:ethnology; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006442:Glycated Hemoglobin / Q000378:metabolism; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000208:ethnology; D006801:Humans; D007730:Kuwait / Q000453:epidemiology; D010375:Pedigree; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D019562:Viral Load
D000998:Antiviral Agents; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D012367:RNA, Viral; C517652:hemoglobin A1c protein, human